AQR Capital Management LLC Has $12.36 Million Position in Teleflex Incorporated (NYSE:TFX)

AQR Capital Management LLC increased its stake in Teleflex Incorporated (NYSE:TFX) by 48.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 59,707 shares of the medical technology company’s stock after purchasing an additional 19,371 shares during the period. AQR Capital Management LLC owned 0.13% of Teleflex worth $12,356,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of TFX. Vanguard Group Inc. lifted its stake in shares of Teleflex by 1.8% during the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock valued at $1,255,408,000 after acquiring an additional 96,711 shares during the period. Janus Henderson Group PLC raised its holdings in Teleflex by 12.0% during the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after purchasing an additional 581,312 shares during the last quarter. Wellington Management Group LLP lifted its position in Teleflex by 2.1% during the 4th quarter. Wellington Management Group LLP now owns 2,496,566 shares of the medical technology company’s stock valued at $622,494,000 after purchasing an additional 52,533 shares during the period. Cooke & Bieler LP boosted its stake in shares of Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after purchasing an additional 172,335 shares during the last quarter. Finally, TD Asset Management Inc grew its position in shares of Teleflex by 12.0% during the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after buying an additional 48,832 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

TFX has been the subject of several recent research reports. Stephens upped their target price on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Truist Financial boosted their target price on Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research report on Monday, August 5th. Finally, Royal Bank of Canada increased their price target on shares of Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $265.57.

Teleflex Price Performance

Shares of TFX opened at $245.13 on Wednesday. The stock has a 50 day simple moving average of $238.41 and a 200 day simple moving average of $221.58. Teleflex Incorporated has a 52-week low of $177.63 and a 52-week high of $257.85. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58. The firm has a market capitalization of $11.55 billion, a PE ratio of 39.35, a P/E/G ratio of 2.24 and a beta of 1.16.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. During the same quarter in the prior year, the company earned $3.41 earnings per share. The business’s quarterly revenue was up .9% compared to the same quarter last year. Sell-side analysts predict that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s dividend payout ratio is 21.83%.

Insider Activity

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now owns 5,496 shares in the company, valued at approximately $1,313,159.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.43% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.